These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1243037)

  • 1. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate.
    Cosnier D; Duchene-Marullaz P; Grimal J; Rispat G; Streichenberger G
    Arzneimittelforschung; 1975 Oct; 25(10):1557-61. PubMed ID: 1243037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity.
    Cosnier D; Hache J; Labrid C; Streichenberger G
    Arzneimittelforschung; 1975; 25(12):1926-33. PubMed ID: 3186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis.
    Cosnier D; Labrid C; Rispat G; Streichenberger G
    Arzneimittelforschung; 1975 Nov; 25(11):1802-6. PubMed ID: 1243090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal experiments on the cardiovascular effects of lofexidine.
    Graf E; Doppelfeld IS; Prop G
    Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between activity and structure in derivatives of clonidine.
    Hoefke W; Kobinger W; Walland A
    Arzneimittelforschung; 1975 May; 25(5):786-93. PubMed ID: 1242325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).
    Scholtysik G; Lauener H; Eichenberger E; Bürki H; Salzmann R; Müller-Schweinitzer E; Waite R
    Arzneimittelforschung; 1975 Oct; 25(10):1483-91. PubMed ID: 1243025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central hypotensive and antihypertensive activities of imidazolidines, structurally related to clonidine.
    Timmermans PB; Van Zwieten PA
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):251-67. PubMed ID: 921415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of guanabenz on the cardiovascular system, in comparison with clonidine and guanethidine].
    Hojo M; Yoshida Y; Nagasaka Y; Machida K; Tatsumi H
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):39-58. PubMed ID: 6852681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of lofexidine in pharmacological screening.
    Wagener HH; Genthe H
    Arzneimittelforschung; 1982; 32(8a):918-23. PubMed ID: 6890365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new centrally acting antihypertensive (ICI 106270) which separates antihypertensive effects from sedation.
    Clough DP; Hatton R; Pettinger SJ
    Arzneimittelforschung; 1981; 31(10):1698-703. PubMed ID: 7198445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.
    Shropshire AT; Wendt RL
    J Pharmacol Exp Ther; 1983 Mar; 224(3):494-500. PubMed ID: 6827474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
    Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ
    Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of a new antihypertensive agent in several species.
    Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
    Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G
    J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the adrenal medulla in the effect of antihypertensive drugs].
    Montastruc JL; Rostin M; Lhoste F; Gaillard-Plaza G; Montastruc P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1647-51. PubMed ID: 3938235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.